Medical Condition News

RSS

Astellas announces positive results from mirabegron phase III trials against OAB

Astellas Pharma Inc. today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder, show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition.

23 Mar 2011

AstraZeneca, Senectus sign deal to identify compounds that trigger cancer cell ageing

Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca's chemical compound library to identify those which trigger a key element of cancer cell ageing - called senescence.

23 Mar 2011

Cardiff study discovers protein that protects pancreatic cells against alcohol effects

A Cardiff University-led study has discovered that a protein provides protection against the effects of alcohol in the pancreas.

23 Mar 2011

Iron deficiency during pregnancy may impact child's brain development

A mother's iron deficiency early in pregnancy may have a profound and long-lasting effect on the brain development of the child, even if the lack of iron is not enough to cause severe anemia, according to a University of Rochester Medical Center study published in the scientific journal PLoS One.

23 Mar 2011

SMR, RTU enter license agreement for RESCULA eye drops

Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.

23 Mar 2011

Positive results from TheraVida THVD-201 Phase 1 trial in patients with OAB, UUI

TheraVida, Inc., a clinical stage biopharmaceutical company developing novel combination drug products, today presented positive results from a Phase 1 clinical trial of its lead product candidate THVD-201 for the treatment of overactive bladder and urge urinary incontinence.

23 Mar 2011

Milk allergy successfully treated with Xolair

A latest study suggests that children with severe milk allergies may be able to rapidly overcome their sensitivities with the help of a biologic drug that helps to quiet an overly aggressive immune response. This is a small study still waiting to be proved in larger populations say researchers.

22 Mar 2011

Greater allowances for overweight bus passengers in U.S.

Because of the growing waistlines of many American bus passengers, the U.S. government may have to rewrite bus safety rules. The Federal Transit Authority (FTA) wants to raise the assumed average weight per bus passenger from 150 pounds to 175 pounds and add an extra quarter of a square foot of floor space per passenger. The agency says the proposals “acknowledge the expanding girth of the average passenger.”

22 Mar 2011

New scientific statement gives guidance to doctors for treatment of blood clots

Doctors are encouraged to consider therapies in addition to blood thinners to treat certain patients with potentially dangerous blood clots that form in the deep veins and travel to the lungs, according to a new scientific statement from the American Heart Association.

22 Mar 2011

Plackers provides Grind-No-More dental night protectors for taxpayers

Tax season is stressful for many Americans, and even the IRS's extension of this year's filing deadline to April 18 may not provide much relief.

22 Mar 2011

Five year course of tamoxifen can offer long-term benefit for women with breast cancer

Experts are urging breast cancer patients to complete their full prescription of tamoxifen, following long-term results from a major Cancer Research UK-funded trial which showed the cancer was less likely to come back in women who took the drug for five years, compared to two years.

22 Mar 2011

Actress invites public to vote for projects that increase AF-related stroke awareness

Today, actress Jane Seymour invites the public to vote for projects that increase awareness of the link between atrial fibrillation and stroke. AF is the most common sustained heart rhythm disorder worldwide and leads to as many as 3 million strokes worldwide each year.

22 Mar 2011

Larger hippocampal volume linked with recovery of PTSD

The hippocampus, a brain region implicated in memory and interpreting environmental contexts, has been the focus of a controversy in posttraumatic stress disorder.

22 Mar 2011

Study to measure lower pressure's impact on kidney disease, cognitive function

Georgia Health Sciences University is enrolling patients in a federally funded study to determine if a lower blood pressure reduces the progression of kidney disease.

22 Mar 2011

Researchers can grow and manipulate personalized gut microbes in laboratory

Each of us carries a unique collection of trillions of friendly microbes in our intestines that helps break down food our bodies otherwise couldn't digest.

22 Mar 2011

Positive results from Meda's Dymista Phase III trial in patients with SAR

Meda announced today positive results from a Phase III clinical trial of Dymista, a novel formulation of azelastine hydrochloride and fluticasone propionate, in patients with seasonal allergic rhinitis.

22 Mar 2011

Shire's Replagal and VPRIV data on Gaucher and Fabry patients presented at ACMG meeting

Shire plc, the global specialty biopharmaceutical company, presented new data for Replagal in patients with Fabry disease, and VPRIV in patients with type 1 Gaucher disease, at the 2011 American College of Medical Genetics' Annual Clinical Genetics Meeting, held in Vancouver, BC, from March 16-20, 2011.

22 Mar 2011

Scientists create organic nanoparticle to treat cancer and deliver drugs

A team of scientists from Princess Margaret Hospital have created an organic nanoparticle that is completely non-toxic, biodegradable and nimble in the way it uses light and heat to treat cancer and deliver drugs.

22 Mar 2011

WHO concerned about radiation levels in food near damaged Japanese nuclear plant

A WHO spokesperson "said on Monday that the detection of radiation in food after an earthquake damaged a Japanese nuclear plant was a more serious problem than had first expected," Reuters reports.

22 Mar 2011

ACE supports HHS' National Strategy for Quality Improvement in Health Care

The Accreditation for Cardiovascular Excellence, a nonprofit organization whose mission is to ensure high-quality patient care and promote patient safety in facilities where invasive cardiac and endovascular procedures are performed, supports the National Strategy for Quality Improvement in Health Care issued today by the U.S. Department of Health and Human Services.

22 Mar 2011

Medical Condition News

Astellas announces positive results from mirabegron phase III trials against OAB

AstraZeneca, Senectus sign deal to identify compounds that trigger cancer cell ageing

Cardiff study discovers protein that protects pancreatic cells against alcohol effects

Iron deficiency during pregnancy may impact child's brain development

SMR, RTU enter license agreement for RESCULA eye drops

Positive results from TheraVida THVD-201 Phase 1 trial in patients with OAB, UUI

Milk allergy successfully treated with Xolair

Greater allowances for overweight bus passengers in U.S.

New scientific statement gives guidance to doctors for treatment of blood clots

Plackers provides Grind-No-More dental night protectors for taxpayers

Five year course of tamoxifen can offer long-term benefit for women with breast cancer

Actress invites public to vote for projects that increase AF-related stroke awareness

Larger hippocampal volume linked with recovery of PTSD

Study to measure lower pressure's impact on kidney disease, cognitive function

Researchers can grow and manipulate personalized gut microbes in laboratory

Positive results from Meda's Dymista Phase III trial in patients with SAR

Shire's Replagal and VPRIV data on Gaucher and Fabry patients presented at ACMG meeting

Scientists create organic nanoparticle to treat cancer and deliver drugs

WHO concerned about radiation levels in food near damaged Japanese nuclear plant

ACE supports HHS' National Strategy for Quality Improvement in Health Care

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News